Philogen announces publication of PET clinical data with proprietary ultra-high affinity FAP-targeting small molecule ligand (OncoFAP)

Philogen announces publication of PET clinical data with proprietary ultra-high affinity FAP-targeting small molecule ligand (OncoFAP) Translational studies performed at the European Institute

Related Keywords

Italy ,Zurich ,Züsz ,Switzerland ,Italian ,Swiss ,Mary Jane Elliott ,Davide Salvi ,Christian Lizak ,Dario Neri ,University Hospital ,Nuclear Medicine ,Italian Stock Exchange ,European Journal Of Nuclear Medicine ,Department Of Nuclear Medicine University ,European Institute For Molecular Imaging ,Consilium Strategic Communications ,European Institute ,Molecular Imaging ,Senn Chemicals ,European Journal ,Chief Executive Officer ,Molecular Imagingand ,Activation Protein ,Proc Natl Acad Sci United States ,Italian Stock ,Emanuele Puca ,Investor Relations ,Strategic Communications ,Jane Elliott ,Philogen ,Nnounces ,Publication ,Linical ,Data ,Roprietary ,Ultra ,Thigh ,Affinity ,Targeting ,Mall ,Olecule ,Migand ,Oncofap ,